Latest SEC Filings

ProCap Financial, Inc.ProCap Financial Reports $37,000 Revenue and $65 Million Net Loss in Q2 2026

ELITE PHARMACEUTICALS INC /NV/Elite Pharmaceuticals Reports Q2 2026 Financial Results with Revenue Decline and Net Income Turnaround

Silver Pegasus Acquisition Corp.Silver Pegasus Acquisition Corp. Reports Financial Results for Quarter Ending June 30, 2026

AmpliTech Group, Inc.AmpliTech Reports 26.8% Revenue Decline in Q2 2026, Despite Growth in Distribution Segment

Sunshine Biopharma, IncSunshine Biopharma Reports Q2 2026 Financial Results with Revenue Decline and Improved Net Loss

Matinas BioPharma Holdings, Inc.Matinas BioPharma Reports $3.25 Million Net Loss, Seeks Funding Amid Strategic Changes

ProMIS Neurosciences Inc.ProMIS Neurosciences Reports $11.7 Million Net Loss and Increased Cash Reserves in Latest 10-Q Filing

My Size, Inc.My Size, Inc. Reports 57% Revenue Increase but Faces Rising Losses and Liquidity Challenges

ORAGENICS INCOragenics Reports $4.7 Million Net Loss and Increased R&D Expenses for First Half of 2026

ARS Pharmaceuticals, Inc.ARS Pharmaceuticals Reports 114% Revenue Growth to $33.7 Million in Q2 2026

Vuzix CorpVuzix Corporation Reports Q2 2026 Financial Results with Revenue Decline and Increased Net Loss

Aktis Oncology, Inc.Aktis Oncology Reports Revenue Growth but Increased Net Loss in Q2 2026

Colombier Acquisition Corp. IIIColombier Acquisition Corp. III Reports $2.4M Net Income for Quarter Ending June 30, 2026

Ideal Power Inc.Ideal Power Inc. Reports Q2 2026 Financial Results with Revenue Increase and Net Loss

ADAPTIN BIO, INC.Adaptin Bio Reports $1.2 Million Net Loss in Q2 2026, Decreases R&D Expenses by 59%

Morgan Stanley Bitcoin TrustMorgan Stanley Bitcoin Trust Reports Financial Performance for Quarter Ending June 30, 2026

Pathfinder Bancorp, Inc.Pathfinder Bancorp Reports $2.7 Million Net Income in Q2 2026

Rank One Computing CorpRank One Computing Corporation Reports Q2 2026 Financial Results with Revenue Growth and Increased Net Loss

Serina Therapeutics, Inc.Serina Therapeutics Reports $13.3 Million Net Loss, Cash Reserves Increase to $23 Million

Inhibrx Biosciences, Inc.Inhibrx Biosciences Reports $36.7 Million Net Loss in Q2 2026

VirTra, IncVirTra Reports 17% Decline in Q2 2026 Net Sales, Operating Loss of $187,464

Yarrow Bioscience, Inc.Yarrow Bioscience Reports Q2 2026 Financial Results with Revenue Increase and Decreased Operating Expenses

FENNEC PHARMACEUTICALS INC.Fennec Pharmaceuticals Reports $1.973M Net Income and $17.874M Revenue in Latest Quarter

NORTHPOINTE BANCSHARES INCNorthpointe Bancshares Reports 18% Increase in Net Income for Q2 2026

NEXTNRG, INC.NextNRG Reports 35.7% Revenue Growth but $17.4 Million Net Loss in Latest Filing